InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C and Quarterly Update 28 Jan 2020 1:19PM $0.090 $0.230 risen by 155.56%
- PharmAust Receives $700k R&D Tax Incentive Refund 14 Jan 2020 2:16PM $0.092 $0.230 risen by 150%
- Epichem Awarded One-Year Contract Extension from DNDi 8 Jan 2020 8:23AM $0.094 $0.230 risen by 144.68%
- Epichem client gives notice to end contract in February 2020 7 Jan 2020 3:14PM $0.110 $0.230 risen by 109.09%
- Expanded Site Recruitment for Phase II MPL Dog Cancer Trial 11 Dec 2019 10:42AM $0.098 $0.230 risen by 134.69%
- Appendix 3B - exercise of options 9 Dec 2019 11:20AM $0.100 $0.230 risen by 130%
- Presentation - Pitt Street Research Life Sciences Conference 28 Nov 2019 8:24AM $0.105 $0.230 risen by 119.05%
- Appendix 3B - exercise of options 21 Nov 2019 12:42PM $0.105 $0.230 risen by 119.05%
- Appendix 3B - exercise of options 8 Nov 2019 12:20PM $0.105 $0.230 risen by 119.05%
- Progress in Recruitment for Phase II Trial in Dogs 4 Nov 2019 8:16AM $0.099 $0.230 risen by 132.32%
- Appendix 4C and Quarterly Update 1 Nov 2019 8:02AM $0.100 $0.230 risen by 130%
- Results of Annual General Meeting 25 Oct 2019 4:46PM $0.115 $0.230 risen by 100%
- AGM Presentation 25 Oct 2019 1:25PM $0.120 $0.230 risen by 91.67%
- Epichem new CEO and Board additions 14 Oct 2019 11:00AM $0.130 $0.230 risen by 76.92%
- Appendix 3B & s708 Notice 10 Oct 2019 5:41PM $0.135 $0.230 risen by 70.37%
- PharmAust Receives Pre-Approval for R&D Tax Rebates 7 Oct 2019 9:09AM $0.150 $0.230 risen by 53.33%
- Epichem Export Business Receives Important WA State Awards 4 Oct 2019 9:20AM $0.150 $0.230 risen by 53.33%
- PharmAust Raises $2.4m in Placement 3 Oct 2019 9:48AM $0.150 $0.230 risen by 53.33%
- Trading Halt 1 Oct 2019 9:14AM $0.150 $0.230 risen by 53.33%
- Appendix 3B - exercise of options 26 Sep 2019 4:42PM $0.155 $0.230 risen by 48.39%
- Notice of Annual General Meeting/Proxy Form 24 Sep 2019 4:07PM $0.155 $0.230 risen by 48.39%
- Appendix 4G & Corporate Governance Statement 19 Sep 2019 5:03PM $0.135 $0.230 risen by 70.37%
- Annual Report 19 Sep 2019 1:58PM $0.135 $0.230 risen by 70.37%
- Appendix 3B - exercise of options 17 Sep 2019 8:21AM $0.135 $0.230 risen by 70.37%
- Agreement with Uni of Melbourne U-Vet for Phase II Dog Trial 10 Sep 2019 8:27AM $0.145 $0.230 risen by 58.62%

376 - 400 of 796 results

Page 16 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.